Skip to content

SANARA MEDTECH INC.: 10-Q filed 2025-11-12

What SANARA MEDTECH INC. reported in its quarterly report filed 2025-11-12 (fiscal Q3 2025): 49 published measures, 142 facts as tagged in accession 0001493152-25-021894.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-12
Fiscal period
fiscal Q3 2025
Accession
0001493152-25-021894 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANARA MEDTECH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3071,088,648USD
At 2024-12-3188,091,992USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3064,948,114USD
At 2024-12-3149,180,030USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-306,148,956USD
At 2024-12-3139,403,573USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-3014,939,646USD
At 2024-12-3115,878,295USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-30,411,153USD92
2025-01-01 to 2025-09-30-35,952,692USD273
2024-07-01 to 2024-09-30-2,857,768USD92
2024-01-01 to 2024-09-30-8,125,966USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-302,841,568USD273
2024-01-01 to 2024-09-30-955,831USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-09-304,543,491USD273
2024-01-01 to 2024-09-30133,676USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-07-01 to 2025-09-3026,333,819USD92
2025-01-01 to 2025-09-3075,572,167USD273
2024-07-01 to 2024-09-3021,671,599USD92
2024-01-01 to 2024-09-3060,367,060USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-308,748,396USD273
2024-01-01 to 2024-09-3018,567,453USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-12,528,613USD273
2024-01-01 to 2024-09-30-6,481,649USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-73,693,846USD
At 2024-12-31-37,784,392USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-308,646,668shares92
2025-01-01 to 2025-09-308,610,538shares273
2024-07-01 to 2024-09-308,517,381shares92
2024-01-01 to 2024-09-308,468,394shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-308,940,734shares92
2025-01-01 to 2025-09-308,907,565shares273
2024-07-01 to 2024-09-308,517,381shares92
2024-01-01 to 2024-09-308,468,394shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3.52USD/shares92
2025-01-01 to 2025-09-30-4.18USD/shares273
2024-07-01 to 2024-09-30-0.34USD/shares92
2024-01-01 to 2024-09-30-0.96USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3.4USD/shares92
2025-01-01 to 2025-09-30-4.04USD/shares273
2024-07-01 to 2024-09-30-0.34USD/shares92
2024-01-01 to 2024-09-30-0.96USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-30417,208USD
At 2024-12-31432,317USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,232,445USD92
2025-01-01 to 2025-09-303,972,788USD273
2024-07-01 to 2024-09-301,025,431USD92
2024-01-01 to 2024-09-303,240,362USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,941,240USD92
2025-01-01 to 2025-09-306,254,079USD273
2024-07-01 to 2024-09-30778,537USD92
2024-01-01 to 2024-09-30-1,001,579USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-3031,225,679USD
At 2024-12-3133,305,988USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,818,105USD92
2025-01-01 to 2025-09-304,926,765USD273
2024-07-01 to 2024-09-30927,577USD92
2024-01-01 to 2024-09-301,839,259USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3017,357,969USD
At 2024-12-3115,290,071USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-09-303,601,781USD
At 2024-12-313,601,781USD
At 2023-12-313,601,781USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-09-3021,100,783USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-3021,518,365USD92
2025-01-01 to 2025-09-3063,671,625USD273
2024-07-01 to 2024-09-3018,901,075USD92
2024-01-01 to 2024-09-3055,477,920USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-303,385,956USD
At 2024-12-312,753,032USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-3024,459,605USD92
2025-01-01 to 2025-09-3069,925,704USD273
2024-07-01 to 2024-09-3019,679,612USD92
2024-01-01 to 2024-09-3054,476,341USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,874,214USD92
2025-01-01 to 2025-09-305,646,463USD273
2024-07-01 to 2024-09-301,991,987USD92
2024-01-01 to 2024-09-305,890,719USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-07-01 to 2025-09-3019,877,875USD92
2025-01-01 to 2025-09-3058,641,402USD273
2024-07-01 to 2024-09-3017,420,347USD92
2024-01-01 to 2024-09-3051,453,311USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,029,591USD92
2025-01-01 to 2025-09-303,036,746USD273
2024-07-01 to 2024-09-30783,840USD92
2024-01-01 to 2024-09-301,945,263USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-308,930,800shares
At 2024-12-318,753,773shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-09-306,140,534USD
At 2025-06-3035,391,946USD
At 2025-03-3136,667,577USD
At 2024-12-3138,911,962USD
At 2024-09-3039,454,275USD
At 2024-06-3041,401,995USD
At 2024-03-3143,011,566USD
At 2023-12-3144,588,017USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-302,154,721USD
At 2024-12-311,447,907USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-09-302,302,465USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-09-3045,089,787USD
At 2024-12-3130,689,290USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-301,047,675USD
At 2024-12-311,040,930USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-30630,467USD
At 2024-12-31608,613USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-09-3021,100,783USD
At 2024-12-3123,481,095USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-12-31748,001USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-30714,115USD
At 2024-12-311,022,464USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-30,412,108USD92
2025-01-01 to 2025-09-30-35,957,889USD273
2025-04-01 to 2025-06-30-2,018,398USD91
2025-01-01 to 2025-03-31-3,527,383USD90
2024-07-01 to 2024-09-30-2,883,052USD92
2024-01-01 to 2024-09-30-8,211,297USD274
2024-04-01 to 2024-06-30-3,529,202USD91
2024-01-01 to 2024-03-31-1,799,043USD91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-07-01 to 2025-09-3041,557USD92
2025-01-01 to 2025-09-30133,165USD273
2024-07-01 to 2024-09-30129,592USD92
2024-01-01 to 2024-09-30395,862USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,277,569USD273
2024-01-01 to 2024-09-303,314,781USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-07-01 to 2025-09-30569,342USD92
2025-01-01 to 2025-09-301,860,312USD273
2024-07-01 to 2024-09-30567,297USD92
2024-01-01 to 2024-09-301,697,935USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,106,747USD92
2025-01-01 to 2025-09-30-5,539,893USD273
2024-07-01 to 2024-09-30-959,025USD92
2024-01-01 to 2024-09-30-1,870,707USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-302,428,062USD273
2024-01-01 to 2024-09-30948,759USD274

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2025-01-01 to 2025-09-30394,149USD273
2024-01-01 to 2024-09-30362,491USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30144,959USD273
2024-01-01 to 2024-09-302,777,243USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-301,122,497USD273
2024-01-01 to 2024-09-30-1,352,923USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-359,968USD273
2024-01-01 to 2024-09-30-622,719USD274

Inspect the source

Entity
SANARA MEDTECH INC. / CIK 0000714256
Captured
2026-09-19T14:58:44.284Z
SEC response SHA-256
f92965785fd765218c7d077735cf7f10feb84c027a40423c2ef31995cf28b81f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000714256.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))